• Cyclosporin A (B1922): Practical Lab Workflow

  2026-09-10

  This dossier-guided article explains how to prepare, apply, and quality-control Cyclosporin A (SKU B1922) for cyclophilin, calcineurin-NFAT, mitochondrial, and cell-response studies. It is appropriate for controlled research assays but should not be used as a water-based formulation or as a substitute for model-specific animal or antiviral dosing evidence.

• Pcbp1, Mitochondrial Integrity, and B Cell Immunity

  2026-09-10

  The reference study identifies Pcbp1 as a posttranscriptional regulator that connects Fdxr mRNA control with mitochondrial complex I integrity, protein translation, and antibody production in B cells. Its findings position mitochondrial quality control as an important determinant of steady-state IgM production, germinal center development, and high-affinity humoral responses.

• Stiripentol LDH Inhibition: Practical Workflows

  2026-09-09

  Use Stiripentol as a research-grade LDH inhibitor to connect lactate flux with neuronal excitability, histone lactylation, and immune-cell behavior. This workflow-led guide covers assay setup, dosing logic, cross-domain applications, and troubleshooting without confusing mechanistic hypotheses with clinical evidence.

• C8-HSL: From Quorum Sensing to Cancer Biology

  2026-09-09

  N-octanoyl-L-Homoserine lactone, or C8-HSL, is moving from a bacterial communication probe toward a broader translational model of host–microbe signaling. This article examines its LuxR-linked biology, reported activation of PI3K/AKT/ERK in lung cancer models, and a practical strategy for converting quorum-sensing observations into reproducible infection biology research.

• S-Adenosylhomocysteine in Neural Assays

  2026-09-08

  Use S-Adenosylhomocysteine (SAH) to test whether methylation pressure contributes to radiation-altered neural differentiation, while separating metabolic effects from PI3K-STAT3-mGluR1 and p53 signaling. This practical guide covers concentration screening, SAM/SAH ratio modulation, assay controls, and troubleshooting in C17.2 and primary neural stem-cell workflows.

• TaqI Restriction Endonuclease Protocol Guide

  2026-09-07

  TaqI Restriction Endonuclease provides rapid, sequence-specific cleavage of plasmid DNA, PCR products, and genomic DNA at the 5′-TCGA-3′ recognition site. It is suited to research workflows requiring sticky-end generation and quick gel-ready digestion, but it should not be used for diagnostic or medical applications.

• Epalrestat in Cell Viability Workflows

  2026-09-07

  Learn how Epalrestat (SKU B1743) can support controlled cell-viability, oxidative-stress, and Parkinson’s disease model workflows. This scenario-based guide covers formulation, experimental controls, mechanistic interpretation, and evidence-based product selection.

• Capecitabine: Mechanism and Preclinical Use

  2026-09-05

  Capecitabine is a fluoropyrimidine prodrug that is enzymatically converted to 5-fluorouracil and studied for tumor-selective chemotherapy mechanisms. Its strongest preclinical value is as a controllable tool for apoptosis, tumor-stroma modeling, and colon cancer research, while patient-derived assembloids clarify why stromal context can alter drug response.

• VX-661 and the Next Era of CFTR Rescue

  2026-09-05

  VX-661, a F508del CFTR corrector, offers more than a trafficking-rescue tool: it provides a way to interrogate how protein folding, calnexin-dependent proteostasis, variant biology, and potentiator timing shape translational cystic fibrosis research.

• DCPS and m7G Signaling in Diabetic Foot Ulcers

  2026-09-04

  A 2025 study identified the m7G-related decapping scavenger enzyme DCPS as a candidate biomarker and regulator of epithelial behavior in diabetic foot ulcers. Its integrated bioinformatics, patient and mouse validation, and keratinocyte knockdown experiments connect reduced DCPS with impaired cell-cycle progression, proliferation, migration, and increased apoptosis.

• v-Agatoxin-IVA and N-Type Calcium Channel Blockade

  2026-09-04

  Sidach and Mintz showed that v-agatoxin-IVA remains a selective high-affinity blocker of P-type calcium channels but can also inhibit N-type currents at higher concentrations. Their voltage-clamp analysis explains why toxin concentration, membrane potential, and cellular context are essential when distinguishing P-, Q-, and N-type channel contributions.

• CP-673451: Selective PDGFRα/β Inhibitor Workflows

  2026-09-03

  CP-673451 enables focused interrogation of PDGFR-α/β signaling, PDGF-BB-driven angiogenesis, and tumor biology with less interference from several neighboring kinases. This practical guide connects phospho-signaling assays, ATRX-stratified glioma experiments, and xenograft readouts to reproducible workflow and troubleshooting decisions.

• Abiraterone acetate in 3D Prostate Cancer Models

  2026-09-02

  Use Abiraterone acetate as a controlled CYP17 inhibitor probe in patient-derived prostate spheroids, where drug penetration, androgen signaling, and tumor heterogeneity can be evaluated together. The workflow below combines formulation-aware handling with orthogonal viability, PSA, immunohistochemistry, and androgen receptor readouts.

• Hoechst 33342 for Live-Cell Nuclear Imaging

  2026-09-02

  Hoechst 33342 supports consistent nuclear segmentation across live-cell imaging, fixed-cell immunofluorescence, and flow cytometry workflows. This practical guide shows how to use the 1 mg/mL reagent to strengthen dermal fibroblast senescence assays without treating nuclear fluorescence as a standalone biological endpoint.

• ATP Workflows for OGDH Metabolism Research

  2026-09-02

  Use ATP to connect mitochondrial enzyme activity, proteostasis, and purinergic signaling in experimentally controlled workflows. This guide translates the TCAIM–OGDH discovery into practical ATP titrations, native-protein assays, extracellular stimulation studies, and troubleshooting decisions.

8538 records 1/570 page Next 12345 下5页 Last page